APN activity has also been proposed as a biomarker of the nephrotoxicity induced by vancomycin [101] or amphotericin B [103] in experimental models and in several human diseases, such as glomerulopathy [104], IgA nephropathy [105], and diabetes [106]. The gene discussed is ANPEP; the disease is diabetes mellitus.